NCT06534762
- Conditions
- Breast Diseases, Breast Neoplasms, Carcinoma, +45 more
- Locations
-
- Zhejiang Provincial People's Hospital Hangzhou, Zhejiang, China
Clinical trial condition
DLBCL - Diffuse Large B Cell Lymphoma
Explore clinical trials studying DLBCL - Diffuse Large B Cell Lymphoma. Study availability and eligibility vary by location and protocol.
41 public trials
24 recruiting studies
DLBCL - Diffuse Large B Cell Lymphoma trial results
NCT06526065
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Universitätsmedizin Göttingen Göttingen, Lower Saxony, Germany
NCT06287398
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, DLBCL, Nos Genetic Subtypes, Dendritic Cell Sarcoma, Interdigitating, +21 more
- Locations
-
- Australasian Leukemia and Lymphoma Group Melbourne, Victoria, Australia
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Incyte Biosciences Italy S.r.l Milan, Italy
Enrolling by Invitation
Long-term Study to Evaluate Safety and Persistence of GF-CART01
NCT06985576
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Follicular Lymphoma (FL), +14 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
Not Yet Recruiting
Orelabrutinib Combined With Induction Therapy Followed by Sequential Monotherapy Maintenance in MCD Subtype Diffuse Large B-cell Lymphoma
NCT07677813
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- The First Bethune Hospital of Jilin University Changchun, Jilin, China
Not Yet Recruiting
A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
NCT07570823
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Beijing Cancer Hospital Beijing, China
Not Yet Recruiting
Study on the Treatment of Double/Triple-hit DLBCL With Chidamide and Lisaftoclax in Combination With Pola-R-CHP
NCT07552324
- Conditions
- DHL, DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +7 more
- Locations
-
Not specified
Not Yet Recruiting
A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping
NCT07511114
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Double Expressor Lymphoma, +6 more
- Locations
-
- No. 197 Ruijin 2nd Road, Huangpu District, Shanghai, Shanghai, Shanghai Shanghai, China
Not Yet Recruiting
Real-World Effectiveness and Safety of Glofitamab in Primary Refractory and Early Relapsed Diffuse Large B-Cell Lymphoma
NCT07472621
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Henan cancer hospital Zhengzhou, Henan, China